[Expert consensus on flow cytometry-based assays for SARS-CoV-2-specific T cells and related operating procedure]

    Zhonghua Yi Xue Za Zhi
    |January 26, 2025
    PubMed

    Insights

    Standardized methods are crucial for assessing SARS-CoV-2-specific T cells, vital for understanding antiviral immunity. This consensus provides guidelines for consistent and comparable T-cell detection across laboratories.

    Area of Science:

    • Immunology
    • Virology
    • Infectious Diseases

    Context:

    • T-cell immune responses are critical for antiviral immunity and evaluating protective immunity.
    • Current lack of standardized assays for antigen-specific T cells hinders consistent evaluation.
    • Assessing SARS-CoV-2-specific T cells is necessary during and after the COVID-19 pandemic.

    Purpose:

    • To establish standardized detection methods and operating procedures for SARS-CoV-2-specific T cells.
    • To reach a consensus on detection methods, biomarker combinations, SOPs, quality control, and data interpretation.
    • To ensure consistency and comparability of results across different laboratories.

    Summary:

    • Experts organized by the Chinese Society of Immunology developed a consensus on detecting SARS-CoV-2-specific T cells.
    • The consensus covers detection methods, biomarker selection, technical protocols, quality control, and data analysis.
    • It aims to standardize the evaluation of T-cell responses to SARS-CoV-2.

    Impact:

    • Provides guiding significance for establishing standard detection methods and operating procedures for SARS-CoV-2-specific T cells.
    • Enhances the consistency and comparability of results from various laboratories.
    • Offers a reference for developing standard detection methods for antigen-specific T cells against other pathogens, like influenza.